Viewing Study NCT02005458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:58 PM
Ignite Modification Date: 2026-05-04 @ 11:07 PM
Study NCT ID: NCT02005458
Status: COMPLETED
Last Update Posted: 2018-07-17
First Post: 2013-12-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy
Sponsor: Xiamen Amoytop Biotech Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Small Cell Lung Cancer View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neutropenia View
None Febrile neutropenia View
None PEG-rhG-CSF View
None Myelosuppressive chemotherapy View